Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway. (Q27851698)
Jump to navigation
Jump to search
scientific article
- Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway. |
scientific article |
|
Statements
2011
0 references
6
0 references
12
0 references
e28973
0 references
14 December 2011
1 reference